Controlled Human Infection Challenge Studies with RSV-Reference-Cited by-同舟云学术

Controlled Human Infection Challenge Studies with RSV

Published:2022 Issue: Volume: Page:
ISSN:0070-217X
Container-title:Current Topics in Microbiology and Immunology
language:
Short-container-title:

Author:

Dayananda Pete,Chiu Christopher,Openshaw Peter

Publisher

Springer Berlin Heidelberg

Link

https://link.springer.com/content/pdf/10.1007/82_2022_257

Reference124 articles.

1. A study of an adenovirus serotype 26 pre-fusion conformation-stabilized F protein (Ad26. RSV. preF) based respiratory syncytial virus (RSV) vaccine in the prevention of lower respiratory tract disease in adults aged 60 years and older—Full text view—ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04908683. Accessed 26 Jan 2022

2. A study of rilematovir in infants and children and subsequently in neonates hospitalized with acute respiratory tract infection due to respiratory syncytial virus (RSV)—Full text view—ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04583280. Accessed 26 Jan 2022

3. Ackerson B, Tseng HF, Sy LS et al (2018) Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis 69:197–203. https://doi.org/10.1093/cid/ciy991

4. Agoti CN, Mwihuri AG, Sande CJ et al (2012) Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya. J Infect Dis 206:1532–1541. https://doi.org/10.1093/infdis/jis570

5. Alansari K, Toaimah FH, Almatar DH et al (2019) Monoclonal antibody treatment of RSV bronchiolitis in young infants: a randomized trial. Pediatrics 143:e20182308. https://doi.org/10.1542/peds.2018-2308

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults;Frontiers in Immunology;2023-10-13

2. A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy;Vaccine;2023-03